ReviewDiagnostics (Basel, Switzerland)2021
The Role of EUS-Guided FNA and FNB in Autoimmune Pancreatitis.
Review in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 31 citations in OpenAlex.
- Comparison of 19-gauge aspiration needles versus 20-gauge forward-bevel needles for diagnosing autoimmune pancreatitis: a single-centre randomised controlled trial.BMC gastroenterology · 2026Trial
- Efficacy of Endoscopic Ultrasound-guided Fine Needle Biopsy With Simplified Macroscopic On-site Evaluation (With Video).DEN open · 2027Article
- Article
- Diagnosis and treatment strategies for autoimmune pancreatitis combined with pancreatic neuroendocrine tumors.World journal of surgical oncology · 2026Review
- Jaundice marks immunoglobulin G4-related cholangitis in type 1 autoimmune pancreatitis patients.Therapeutic advances in gastroenterology · 2026Article
- Role of endoscopic ultrasound in diagnosis and management of autoimmune pancreatitis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025Review
- Endoscopic Diagnostics for IgG4-Related Pancreatobiliary Diseases: Current Modalities and Clinical Perspectives.Diagnostics (Basel, Switzerland) · 2025Review
- Management of acute pancreatitis in the "no man's land".Internal and emergency medicine · 2025Review
- 19-Gauge Versus 22-Gauge Franseen Needles, Comparison of the Histological Diagnostic Capability of Endoscopic Ultrasound-Guided Fine-Needle Biopsy for Autoimmune Pancreatitis: A Multicenter Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2025Article
- Endoscopic ultrasound-guided fine-needle aspiration value in suspected autoimmune pancreatitis malignancy diagnosis.CytoJournal · 2025Article
- Pancreatic Cancer Mimicking Relapse of Autoimmune Pancreatitis: Case Reports.Surgical case reports · 2025Article
- Response to "Is it time to revise criteria and treatment of type 2 AIP?"United European gastroenterology journal · 2024Article
- The Role of Endoscopic Ultrasound and Ancillary Techniques in the Diagnosis of Autoimmune Pancreatitis: A Comprehensive Review.Diagnostics (Basel, Switzerland) · 2024Review
- Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis.United European gastroenterology journal · 2024Observational
- Article
- Autoimmune pancreatitis: Cornerstones and future perspectives.World journal of gastroenterology · 2024Review
- Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions.Visceral medicine · 2023Review
- The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions.Journal of clinical medicine · 2023Review
- Challenges for clinicians treating autoimmune pancreatitis: Current perspectives.World journal of clinical cases · 2023Review
- Autoimmune pancreatitis: A bibliometric analysis from 2002 to 2022.Frontiers in immunology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune pancreatitis (AIP) is an increasingly recognized disease classified into two different subtypes based on histology. According to the International Diagnostic Criteria (ICDC), the diagnosis is achieved using a combination of different criteria. In patients presenting with a typical imaging appearance, the diagnosis may be straightforward, and steroid treatment is recommended, even without histological confirmation. In patients with atypical imaging or mass-forming appearance, the differential diagnosis with pancreatic cancer is challenging and crucial for treatment strategy. Endoscopic ultrasound (EUS)-guided tissue acquisition has been proposed to achieve a histological diagnosis. Fine-needle aspiration (FNA) was first proposed to aspirate cells from pancreatic lesions. Despite excellent results in terms of sensitivity for pancreatic cancer, the data are disappointing regarding the diagnosis of AIP. The recent development of new needles allowing fine-needle biopsy (FNB) has been associated with improved diagnostic accuracy based on preserving the tissue architecture, which is necessary to detect the typical histological features of AIP. However, the published literature on the role of EUS-guided FNA and FNB is limited and mainly focused on type 1 AIP. The present study aimed to review the available literature on the role of EUS-guided FNA and FNB in the diagnosis of AIP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.